<DOC>
	<DOCNO>NCT02419716</DOCNO>
	<brief_summary>This prospective longitudinal study assess impact repeat Cologuard test 3 year average risk patient .</brief_summary>
	<brief_title>A Study Cologuardâ„¢ Average Risk Population Assessing Three Year Test Interval</brief_title>
	<detailed_description>This prospective longitudinal study assess impact repeat Cologuard test 3 year average risk patient . Enrolled subject prescribe Cologuard per approve label baseline . Subjects positive result refer colonoscopy study participation complete . Subjects negative Cologuard result see annually 3 year . At year 3 , subject repeat Cologuard , follow colonoscopy , regardless Cologuard test outcome . Subjects colonoscopy time study discontinue follow collection colonoscopy associate histopathology result .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>1 . Subject prescribed Cologuard colorectal cancer screen 2 . Subject average risk development colorectal cancer 3 . Subject 50 year old 4 . Subject willing able sign inform consent . 1 . Subject colonoscopy previous 9 year 2 . Subject undergone doublecontrast barium enema , virtual ( CTbased ) colonoscopy , flexible sigmoidoscopy within previous five ( 5 ) year . 3 . Subject positive fecal occult blood test FIT within previous six ( 6 ) month . 4 . Subject condition opinion investigator preclude participation study ( e.g. , subject eligible diagnostic colonoscopy ) . 5 . Subject history colorectal cancer advance adenoma . 6 . Subject history aerodigestive tract cancer 7 . Subject prior colorectal resection reason sigmoid diverticular disease 8 . Subject overt rectal bleeding , e.g . hematochezia melena , within previous 30 day . ( Blood toilet paper , wipe , constitute rectal bleeding ) 9 . Subject diagnosis personal history follow highrisk condition colorectal cancer : Inflammatory bowel disease ( IBD ) include chronic ulcerative colitis ( CUC ) Crohn 's disease . 2 firstdegree relative diagnose colon cancer . ( Note : firstdegree relative include parent , sibling offspring ) . One firstdegree relative CRC diagnose age 60 . 10 . Subject family history : Familial adenomatous polyposis ( also refer `` FAP '' , include attenuate FAP ) . Hereditary nonpolyposis colorectal cancer syndrome ( also refer `` HNPCC '' `` Lynch Syndrome '' ) . Other hereditary cancer syndrome include limited PeutzJeghers Syndrome , MYHAssociated Polyposis ( MAP ) , Gardner 's Syndrome , Turcot 's ( Crail 's ) Syndrome , Cowden 's Syndrome , Juvenile Polyposis , CronkhiteCanada Syndrome , Neurofibromatosis Familial Hyperplastic Polyposis .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>Colorectal cancer screen</keyword>
</DOC>